Asghari V, Schoots O, van Kats S, Ohara K, Jovanovic V, Guan H C, Bunzow J R, Petronis A, Van Tol H H
Department of Psychiatry, Clarke Institute of Psychiatry, Toronto, Ontario, Canada.
Mol Pharmacol. 1994 Aug;46(2):364-73.
Recent molecular characterization of the human D4 gene has revealed the existence of various polymorphic forms of this receptor. These variations are found in the putative third cytoplasmic loop region and encode a variable number of repeats of 16 amino acids in length. In the present study we have compared the pharmacological binding profiles of seven different polymorphic variants of the human D4 receptor, the rat D4 receptor, and two different human D4 receptor mutants that were deleted in the repeat sequence. For this purpose we cloned the rat D4 receptor gene and compared its gene structure and its pharmacological binding profile with those of the D4.4 and D4.7 genes. The rat and human D4 genes display a high degree of sequence similarity, especially in the coding regions. An Alu repeat sequence was identified in the first intron of the human D4 gene but is not present in the rat D4 gene. Furthermore, using the polymerase chain reaction we cloned 3-, 5-, 6-, and 9-fold repeat sequences. These cloned repeat sequences were used for the reconstruction of full length cDNAs encoding D4.3, D4.5, D4.6, and D4.9, respectively. These novel forms of the human D4 receptor, as well as the previously cloned D4.2, D4.4, and D4.7 forms, were transiently expressed in COS-7 cells. All of the different forms of the human and rat D4 receptors and repeat deletion mutants displayed similar binding profiles for all ligands tested, although small differences were observed. The affinity for dopamine could be decreased by guanosine-5'-(beta, gamma-imido)triphosphate with the different forms of the D4 receptor, including the two receptor mutants that were deleted in the repeat sequence. These data suggest that the polymorphic repeat sequence has little influence on D4 binding profiles and might not be essential for G protein interaction.
近期对人类D4基因的分子特征分析揭示了该受体存在多种多态性形式。这些变异存在于假定的第三胞质环区域,编码长度为16个氨基酸的可变重复序列。在本研究中,我们比较了人类D4受体的七种不同多态性变体、大鼠D4受体以及在重复序列中缺失的两种不同人类D4受体突变体的药理学结合谱。为此,我们克隆了大鼠D4受体基因,并将其基因结构和药理学结合谱与D4.4和D4.7基因进行了比较。大鼠和人类D4基因显示出高度的序列相似性,尤其是在编码区域。在人类D4基因的第一个内含子中鉴定出一个Alu重复序列,但大鼠D4基因中不存在。此外,我们利用聚合酶链反应克隆了3倍、5倍、6倍和9倍的重复序列。这些克隆的重复序列分别用于重建编码D4.3、D4.5、D4.6和D4.9的全长cDNA。人类D4受体的这些新形式,以及先前克隆的D4.2、D4.4和D4.7形式,在COS-7细胞中瞬时表达。尽管观察到了微小差异,但所有不同形式的人类和大鼠D4受体以及重复缺失突变体对所有测试配体都显示出相似的结合谱。鸟苷-5'-(β,γ-亚氨基)三磷酸可降低不同形式D4受体对多巴胺的亲和力,包括在重复序列中缺失的两种受体突变体。这些数据表明,多态性重复序列对D4结合谱影响很小,可能对G蛋白相互作用并非必不可少。